|
|
-
|
COVID-19 vaccine Janssen (Ad26.COV2-S…
|
COVID-19 vaccine (Ad26.COV2-S [recombinant])
|
Cancelled by PPB
|
|
Details →
|
|
|
H2021/CTD8692/20203EUA
|
COVID-19 VACCINE JANSSEN (AD26.COV2-S [RECOMBINANT])
|
COVID-19 VACCINE (AD26.COV2-S [RECOMBINANT])
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Revoked
|
Details →
|
|
|
H2019/4435/150ER
|
INVEGA SUSTENNA
|
PALIPERIDONE PALMITATE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2019/4434/152ER
|
INVEGA SUSTENNA 117
|
PALIPERIDONE PALMITATE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2019/4436/149ER
|
INVEGA SUSTENNA 234
|
PALIPERIDONE PALMITATE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2019/4436/149ER/R1
|
INVEGA SUSTENNA 234
|
PALIPERIDONE PALMITATE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2019/4433/151ER
|
INVEGA SUSTENNA 78
|
PALIPERIDONE PALMITATE
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2016/CTD 2475/276/R1
|
Concerta 27mg extended-release tablet
|
Methylphenidate Hydrochloride
|
Janssen Pharmaceuticals, Inc
|
Retained
|
Details →
|
|
|
H2016/CTD2475/276/R1
|
Concerta 27mg extended-release tablet
|
Methylphenidate Hydrochloride
|
Janssen Pharmaceuticals, Inc
|
Retained
|
Details →
|
|
|
H2016/CTD 2476/275/R1
|
Concerta 36mg extended-release tablet
|
methylphenidate hydrochloride
|
Janssen Pharmaceuticals, Inc
|
Retained
|
Details →
|
|
|
H2018/4832/173ER
|
INVEGA® 9 MG PROLONGED-RELEASE TABLETS
|
PALIPERIDONE
|
PHILLIPS THERAPEUTICS LIMITED
|
Registered
|
Details →
|
|
|
H2026/CTD13197/26053
|
STELARA 130MG CONCENTRATE FOR SOLUTION FOR INFUSION
|
USTEKINUMAB
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2015/CTD3938/468
|
INTELENCE 25 MG
|
ETRAVIRINE
|
Janssen-Cilag International NV
|
Withdrawn Voluntarily by MAH
|
Details →
|
|
|
H2018/CTD4469/157ER
|
VOKANAMET
|
CANAGLIFLOZIN / METFORMIN
|
PHILLIPS PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2025/CTD7147/13381
|
ZYTIGA®
|
ABIRATERONE ACETATE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2022/CTD6606/22832
|
TREVICTA® 175MG
|
PALIPERIDONE PALMITATE
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2022/CTD6609/12835
|
TREVICTA® 263MG
|
PALIPERIDONE PALMITATE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2022/CTD6616/12877
|
TREVICTA® 350MG
|
PALIPERIDONE PALMITATE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2022/CTD6626/12895
|
TREVICTA® 525MG
|
PALIPERIDONE PALMITATE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2026/CTD11742/24074
|
ERLEADA TABLET
|
APALUTAMIDE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|